In Ulcerative colitis Ulcerative colitis is a disease of the large intestine (colon) and rectum in which the lining of the bowel becomes red and swollen. This can lead to bleeding, frequent diarrhea, and abdominal pain. Mesacol Suppository can relieve these symptoms and also help you to stay well by preventing them from coming back. It is taken by the back passage (rectal route) and should not be taken orally. You need to use this medicine regularly to get the most out of it and you should drink plenty of fluids to make sure you stay hydrated. In Crohn’s disease Crohn’s disease is a chronic (long-term) inflammatory disease of the intestines. The most common symptoms are diarrhea and pain in your abdomen. Mesacol Suppository helps reduce the inflammation, relieve the symptoms, and prevent them from coming back (keep you in remission).
No interaction found/established
Mesacol Suppository may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Mesacol Suppository is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. If you are taking Mesacol Suppository, monitor the baby for diarrhea.
No interaction found/established
Mesacol Suppository should be used with caution in patients with kidney disease. Dose adjustment of Mesacol Suppository may be needed. Please consult your doctor. Use of Mesacol Suppository is not recommended in patients with severe kidney disease.
Mesacol Suppository should be used with caution in patients with liver disease. Dose adjustment of Mesacol Suppository may be needed. Please consult your doctor.
If you miss a dose of Mesacol Suppository, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Taj Pharma India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Taj Pharma India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ferring Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Novartis India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Elder Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)